ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

ClinicalTrials.gov ID: NCT01664247

Public ClinicalTrials.gov record NCT01664247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01664247
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
346 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2012
Primary completion
Dec 30, 2013
Completion
Dec 30, 2013
Last update posted
Sep 24, 2017

2012 – 2013

United States locations

U.S. sites
67
U.S. states
24
U.S. cities
62
Facility City State ZIP Site status
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Huntington Beach California 92648
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Monterey California 93940
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Boynton Beach Florida 33472
Novo Nordisk Investigational Site Clearwater Florida 33765
Novo Nordisk Investigational Site Hollywood Florida 33021
Novo Nordisk Investigational Site Jacksonville Florida 32207
Novo Nordisk Investigational Site Miami Florida 33135
Novo Nordisk Investigational Site Miami Florida 33156
Novo Nordisk Investigational Site New Port Richey Florida 34652
Novo Nordisk Investigational Site Palm Harbor Florida 34684
Novo Nordisk Investigational Site Tampa Florida 33603
Novo Nordisk Investigational Site Decatur Georgia 30033
Novo Nordisk Investigational Site Perry Georgia 31069
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Paducah Kentucky 42003
Novo Nordisk Investigational Site Metairie Louisiana 70002
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Buckley Michigan 49620
Novo Nordisk Investigational Site Chesterfield Missouri 63017-3632
Novo Nordisk Investigational Site Henderson Nevada 89052-2649
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site Smithtown New York 11787
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517
Novo Nordisk Investigational Site Greensboro North Carolina 27408
Novo Nordisk Investigational Site Morehead City North Carolina 28557
Novo Nordisk Investigational Site Cincinnati Ohio 45255
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19152
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Simpsonville South Carolina 29681
Novo Nordisk Investigational Site Chattanooga Tennessee 37404-1192
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Humboldt Tennessee 38343
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390
Novo Nordisk Investigational Site Houston Texas 77030-2703
Novo Nordisk Investigational Site Irving Texas 75061-2210
Novo Nordisk Investigational Site Lubbock Texas 79423
Novo Nordisk Investigational Site Round Rock Texas 78681
Novo Nordisk Investigational Site San Antonio Texas 78224
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site St. George Utah 84790
Novo Nordisk Investigational Site Newport News Virginia 23606
Novo Nordisk Investigational Site Spokane Washington 99218
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01664247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2017 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01664247 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →